{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:19:21Z","timestamp":1789993161714,"version":"4.0.1"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T00:00:00Z","timestamp":1240790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:italic>\n            <jats:bold>Aim.<\/jats:bold> To evaluate the association between coping self\u2010efficacy and persistent use of heroin by patients enrolled in a methadone treatment program. <jats:bold>Design and Methods.<\/jats:bold> Cross\u2010sectional survey. One hundred and ninety\u2010one patients attending outpatient methadone clinics in South\u2010East England, United Kingdom. Validated questionnaires were used to assess drug use (Maudsley Addiction Profile), alcohol use (Alcohol Use Disorders Identification Test), mental health (Hospital Anxiety and Depression Scale) and coping self\u2010efficacy (brief 8\u2010item Drug Taking Confidence Questionnaire). <jats:bold>Results.<\/jats:bold> Half of the participants (95\/191) reported heroin use in the preceding 14\u2010day period. Heroin use during methadone treatment was associated with financial problems (<\/jats:italic>P\u2003=\u2003<jats:italic>0.008), spending time with other drug users (<\/jats:italic>P\u2003&lt;\u2003<jats:italic>0.001), cocaine use (<\/jats:italic>P\u2003=\u2003<jats:italic>0.002), low mood (<\/jats:italic>P\u2003=\u2003<jats:italic>0.002) and dissatisfaction with the daily methadone dose (<\/jats:italic>P\u2003=\u2003<jats:italic>0.014). Compared with \u2018Heroin\u2010abstinent\u2019 patients, the \u2018Heroin\u2019 group reported significantly lower mean coping self\u2010efficacy scores (<\/jats:italic>t\u2003=\u2003<jats:italic>9.8, d.f.\u2003=\u2003182,<\/jats:italic> P\u2003&lt;\u2003<jats:italic>0.001, effect size 1.17). After correcting for the effects of co\u2010variants in a logistic regression model, the main determinants of persistent heroin use were \u2018coping self\u2010efficacy\u2019[B \u22120.05; standard error (SE) 0.008; Wald 36.6; odds ratio (OR) 0.95, 95% confidence interval (CI) 0.94, 0.97;<\/jats:italic> P\u2003&lt;\u2003<jats:italic>0.001] and \u2018dissatisfaction with methadone dose\u2019 (B 0.93; SE 0.46; Wald 4.1; OR 2.5, 95% CI 1.03, 6.25;<\/jats:italic> P\u2003=\u2003<jats:italic>0.042). Satisfaction with methadone dose showed no association with self\u2010efficacy. <jats:bold>Discussion and Conclusions.<\/jats:bold> While heroin use during methadone treatment can partly be explained by inadequate dosing, our data suggest a more complex picture with significant contribution from poor coping self\u2010efficacy. Efforts aimed at enhancing and maintaining the patients' self\u2010efficacy and social skills are likely to improve heroin and other drug use outcomes with added benefits for treatment completion rates and the throughput of methadone programs.<\/jats:italic>[Senbanjo R, Wolff K, Marshall EJ, Strang J. Persistence of heroin use despite methadone treatment: Poor coping self\u2010efficacy predicts continued heroin use. <jats:italic>Drug Alcohol Rev<\/jats:italic> 2009]<\/jats:p>","DOI":"10.1111\/j.1465-3362.2009.00064.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T11:14:14Z","timestamp":1281957254000},"page":"608-615","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Persistence of heroin use despite methadone treatment: Poor coping self\u2010efficacy predicts continued heroin use"],"prefix":"10.1111","volume":"28","author":[{"given":"RICHARD","family":"SENBANJO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIM","family":"WOLFF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. JANE","family":"MARSHALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"STRANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta11090"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1995.90682310.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.4.395"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01232.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.11.009"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/09687630600997071"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00132-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1201\/b14312-18"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00728.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.015"},{"key":"e_1_2_5_12_2","first-page":"393","article-title":"Factors affecting the outcome of methadone maintenance treatment in opiate dependence","volume":"100","author":"Kamal F","year":"2007","journal-title":"Ir Med J"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.95.8s2.4.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.931738.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01362.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1201\/b14312-8"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.59.4.224"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.2466\/PR0.86.2.529-538"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00227.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.63.1.158"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.02.003"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9312185711.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb02093.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(01)00296-3"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-29"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.94572310.x"},{"key":"e_1_2_5_27_2","volume-title":"The national treatment outcome research study: changes in substance use, health and criminal behaviour during the five years after intake","author":"Gossop M","year":"2001"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.08.002"},{"key":"e_1_2_5_29_2","first-page":"71","volume-title":"Encyclopedia of human behaviour","author":"Bandura A","year":"1994"},{"key":"e_1_2_5_30_2","first-page":"43","article-title":"Psychosocial treatments for substance use disorders. Guiding principles for promoting behavioral change","volume":"13","author":"Carpenter KM","year":"2006","journal-title":"Prim psychiatry"},{"key":"e_1_2_5_31_2","volume-title":"The effectiveness of psychological therapies on drug misusing clients","author":"Wanigaratne S","year":"2005"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01320.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.06.037"},{"key":"e_1_2_5_34_2","volume-title":"At the sharp end: 21st century injecting drug use","author":"Turning Point","year":"2007"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v14n01_07"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n01_07"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.85.1.83"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.9.817"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/026988110401800321"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1465-3362.2009.00064.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1465-3362.2009.00064.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:13:45Z","timestamp":1696950825000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1465-3362.2009.00064.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1465-3362.2009.00064.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1465-3362.2009.00064.x","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"2009-11-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}